Skip to main content

Peer Review reports

From: The 90% effective dose (ED90) of remimazolam for inhibiting responses to the insertion of a duodenoscope during ERCP

Original Submission
21 Aug 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Nov 2023 Author responded Author comments - Jian-bo Yu
Resubmission - Version 3
19 Nov 2023 Submitted Manuscript version 3
21 Nov 2023 Author responded Author comments - Jian-bo Yu
Resubmission - Version 4
21 Nov 2023 Submitted Manuscript version 4
9 Dec 2023 Reviewed Reviewer Report
16 Mar 2024 Reviewed Reviewer Report
24 Apr 2024 Author responded Author comments - Jian-bo Yu
Resubmission - Version 5
24 Apr 2024 Submitted Manuscript version 5
25 Apr 2024 Author responded Author comments - Jian-bo Yu
Resubmission - Version 6
25 Apr 2024 Submitted Manuscript version 6
28 Apr 2024 Author responded Author comments - Jian-bo Yu
Resubmission - Version 7
28 Apr 2024 Submitted Manuscript version 7
1 May 2024 Author responded Author comments - Jian-bo Yu
Resubmission - Version 8
1 May 2024 Submitted Manuscript version 8
2 May 2024 Author responded Author comments - Jian-bo Yu
Resubmission - Version 9
2 May 2024 Submitted Manuscript version 9
3 May 2024 Author responded Author comments - Jian-bo Yu
Resubmission - Version 10
3 May 2024 Submitted Manuscript version 10
Publishing
6 May 2024 Editorially accepted
14 May 2024 Article published 10.1186/s12871-024-02554-1

You can find further information about peer review here.

Back to article page